Target intelligence / Profile preview

microRNA 6780a (MIR6780A)

Target
MIR6780A
Molecular classification
MicroRNA
01

Overview

microRNA 6780a (MIR6780A) is a non-coding RNA molecule classified as a microRNA (miRNA) and is involved in post-transcriptional regulation of gene expression by binding to target mRNA sequences, leading to their degradation or translational inhibition[4][2]. There is little evidence from current literature and recognized genetic databases indicating that "microRNA 6780a" (MIR6780A) itself is a well-established, functionally studied, or clinically recognized miRNA in humans. MicroRNAs are short (~22 nucleotide) non-coding RNA molecules that regulate gene expression by binding to complementary sequences on target messenger RNA transcripts, thus silencing or degrading them[4][2]. The canonical biogenesis of a microRNA involves processing of a primary transcript (pri-miRNA) by DROSHA and DICER enzymes, yielding mature miRNA that integrates into the RNA-induced silencing complex (RISC) and guides it to target mRNAs[2]. MicroRNAs are crucial in many biological processes such as cell differentiation, proliferation, apoptosis, and cancer biology[1][3][5]. The specific molecule "microRNA 6780a" (MIR6780A), with aliases including "hsa-mir-6780a," appears to follow standard miRNA naming conventions, but there is no significant published evidence of its functional characterization, disease association, or therapeutic targeting as of late 2025. In general, miRNAs may play roles in cancer, immune regulation, and development, but there is no indication that microRNA 6780a itself meets criteria as a recognized therapeutic target, biomarker, or mechanistically significant molecule[1][4][3]. Notable limitation: - The information on "microRNA 6780a" (MIR6780A) is not supported by well-indexed genomic, pharmacological, or disease databases at this time. The entry may be misspelled, hypothetical, not curated in major reference sources, or reflect a molecule not yet characterized in peer-reviewed literature. If you need details for a different or well-characterized microRNA, please specify.

Other names
hsa-mir-6780amicroRNA mir-6780aMIR6780A

Beyond the preview

Go deeper on microRNA 6780a (MIR6780A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on microRNA 6780a (MIR6780A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call